Literature DB >> 36243825

Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients.

Atefeh Najmadini1, Mohammad Mahdi Mohammadi2, Ladan Langroudi1, Hosseinali Ebrahimi Meimand3, Merat Mahmoodi1, Moghadameh Mirzaei4.   

Abstract

Multiple sclerosis (MS) is one of the common autoimmune diseases. The exact etiology of MS is still unclear, but recent studies have shown the possibility of infectious agent involvement such as Epstein-Barr virus (EBV) in MS pathophysiology. In this study, CD3 + CD8 + T cells of 25 new case MS patients were compared with healthy donors for expression of exhaustion marker, PD-1, using flow cytometry. Also, the expression of the EBV gene, BRCF-1, in PBMCs was analyzed using real-time PCR. Results revealed a lower frequency of CD3 + CD8 + T cells in MS patients. Also, increased expression of PD-1 was observed on CTLs which correlated with higher viral loads. Therefore, a lower frequency of CD8 + T cells but a higher exhaustion marker in MS patients reveals a new mechanism of EBV pathogenesis in MS development. The results suggest that inefficient immune control of EBV in patients with MS may cause exacerbation of the disease. Future studies on the mechanism of T cell exhaustion and chronic infections may aid in a better understanding of the disease and the design of effective therapies.
© 2022. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Epstein-Barr virus; Multiple sclerosis; PD-1; T cell exhaustion

Year:  2022        PMID: 36243825     DOI: 10.1007/s13365-022-01083-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  2 in total

Review 1.  Multiple sclerosis outcomes after cancer immunotherapy.

Authors:  Catherine R Garcia; Rani Jayswal; Val Adams; Lowell B Anthony; John L Villano
Journal:  Clin Transl Oncol       Date:  2019-02-20       Impact factor: 3.405

2.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.

Authors:  Kjetil Bjornevik; Marianna Cortese; Kassandra L Munger; Alberto Ascherio; Brian C Healy; Jens Kuhle; Michael J Mina; Yumei Leng; Stephen J Elledge; David W Niebuhr; Ann I Scher
Journal:  Science       Date:  2022-01-13       Impact factor: 63.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.